Personal tools

Coexpression cluster:C92: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Coexpression_clusters
{
|coexpression_dpi_cluster_scores_median=0,0,

Latest revision as of 10:29, 17 September 2013


Full id: C92_CD14CD16_CD14_Eosinophils_Basophils_Neutrophils_Macrophage_Whole



Phase1 CAGE Peaks

Hg19::chr10:101379080..101379085,+p@chr10:101379080..101379085
+
Hg19::chr10:104556220..104556247,-p@chr10:104556220..104556247
-
Hg19::chr10:104556407..104556425,+p@chr10:104556407..104556425
+
Hg19::chr10:114594528..114594539,-p@chr10:114594528..114594539
-
Hg19::chr10:114885446..114885465,+p@chr10:114885446..114885465
+
Hg19::chr10:115070193..115070207,-p@chr10:115070193..115070207
-
Hg19::chr10:115080077..115080087,-p@chr10:115080077..115080087
-
Hg19::chr10:43609342..43609351,+p@chr10:43609342..43609351
+
Hg19::chr10:73473819..73473836,+p@chr10:73473819..73473836
+
Hg19::chr10:73534273..73534295,-p@chr10:73534273..73534295
-
Hg19::chr10:73588893..73588912,-p@chr10:73588893..73588912
-
Hg19::chr10:81742364..81742375,-p2@SFTPD
Hg19::chr11:117056662..117056716,+p7@SIDT2
Hg19::chr11:117056719..117056726,+p28@SIDT2
Hg19::chr11:117056730..117056740,+p15@SIDT2
Hg19::chr11:117056889..117056905,+p21@SIDT2
Hg19::chr11:122614916..122614928,+p@chr11:122614916..122614928
+
Hg19::chr11:2323009..2323021,-p7@C11orf21
Hg19::chr11:2905326..2905374,-p@chr11:2905326..2905374
-
Hg19::chr11:504207..504213,+p@chr11:504207..504213
+
Hg19::chr11:60146107..60146118,+p6@MS4A7
Hg19::chr11:67051186..67051245,+p3@ADRBK1
Hg19::chr11:67415202..67415246,-p5@ACY3
Hg19::chr12:117504933..117504940,-p@chr12:117504933..117504940
-
Hg19::chr12:121976319..121976333,-p@chr12:121976319..121976333
-
Hg19::chr12:123752764..123752835,-p7@CDK2AP1
Hg19::chr12:123752843..123752879,-p10@CDK2AP1
Hg19::chr12:12871327..12871345,+p@chr12:12871327..12871345
+
Hg19::chr12:29727591..29727616,-p@chr12:29727591..29727616
-
Hg19::chr14:101150099..101150117,+p@chr14:101150099..101150117
+
Hg19::chr14:101150133..101150145,+p@chr14:101150133..101150145
+
Hg19::chr14:105954292..105954314,+p7@CRIP1
Hg19::chr14:23282256..23282282,-p17@SLC7A7
Hg19::chr14:52782082..52782100,-p@chr14:52782082..52782100
-
Hg19::chr14:52782111..52782133,-p@chr14:52782111..52782133
-
Hg19::chr14:92927429..92927462,+p@chr14:92927429..92927462
+
Hg19::chr14:92927464..92927488,+p@chr14:92927464..92927488
+
Hg19::chr15:22538560..22538601,-p@chr15:22538560..22538601
-
Hg19::chr15:22550722..22550726,+p@chr15:22550722..22550726
+
Hg19::chr15:38296918..38296944,+p1@ENST00000557883
Hg19::chr15:75080883..75080890,+p14@CSK
Hg19::chr15:75422284..75422300,-p@chr15:75422284..75422300
-
Hg19::chr15:86098640..86098665,+p13@AKAP13
Hg19::chr16:1538765..1538796,-p1@PTX4
Hg19::chr16:1538881..1538887,+p@chr16:1538881..1538887
+
Hg19::chr16:17460967..17460974,-p@chr16:17460967..17460974
-
Hg19::chr16:19179856..19179908,+p2@SYT17
Hg19::chr16:30484090..30484101,+p4@ITGAL
Hg19::chr16:4563100..4563144,-p12@C16orf5
Hg19::chr16:50313353..50313370,+p@chr16:50313353..50313370
+
Hg19::chr16:67429107..67429142,-p@chr16:67429107..67429142
-
Hg19::chr16:67429148..67429159,-p@chr16:67429148..67429159
-
Hg19::chr16:67429168..67429188,-p@chr16:67429168..67429188
-
Hg19::chr16:68032947..68032953,+p@chr16:68032947..68032953
+
Hg19::chr16:85096580..85096602,+p3@KIAA0513
Hg19::chr17:40351201..40351230,+p@chr17:40351201..40351230
+
Hg19::chr17:47287786..47287800,-p@chr17:47287786..47287800
-
Hg19::chr17:47288020..47288029,+p3@ABI3
Hg19::chr17:48870630..48870661,+p@chr17:48870630..48870661
+
Hg19::chr17:531650..531657,-p@chr17:531650..531657
-
Hg19::chr17:531669..531692,-p@chr17:531669..531692
-
Hg19::chr17:531709..531723,-p@chr17:531709..531723
-
Hg19::chr17:61776536..61776553,-p@chr17:61776536..61776553
-
Hg19::chr17:61776579..61776588,-p@chr17:61776579..61776588
-
Hg19::chr17:61777090..61777112,-p7@LIMD2
Hg19::chr17:72439704..72439736,+p8@GPRC5C
Hg19::chr17:72563495..72563524,-p3@ENST00000425002
Hg19::chr17:72563552..72563583,-p1@ENST00000425002
Hg19::chr17:72563586..72563601,-p5@ENST00000425002
Hg19::chr17:72563622..72563633,-p4@ENST00000425002
Hg19::chr17:72563639..72563654,-p2@ENST00000425002
Hg19::chr17:72595953..72595966,+p@chr17:72595953..72595966
+
Hg19::chr17:72595971..72595990,+p@chr17:72595971..72595990
+
Hg19::chr17:72595995..72596020,+p@chr17:72595995..72596020
+
Hg19::chr17:75430998..75431040,+p@chr17:75430998..75431040
+
Hg19::chr17:75440858..75440875,+p1@ENST00000450721
Hg19::chr17:76123130..76123168,-p13@TMC6
Hg19::chr17:80064388..80064407,-p@chr17:80064388..80064407
-
Hg19::chr17:80843910..80843933,+p@chr17:80843910..80843933
+
Hg19::chr17:81103313..81103332,-p@chr17:81103313..81103332
-
Hg19::chr18:13569295..13569309,+p@chr18:13569295..13569309
+
Hg19::chr19:10959147..10959176,+p2@C19orf38
Hg19::chr19:14546214..14546245,+p@chr19:14546214..14546245
+
Hg19::chr19:14887911..14887932,-p3@EMR2
Hg19::chr19:18283959..18283993,+p@chr19:18283959..18283993
+
Hg19::chr19:18507990..18508011,-p3@LRRC25
Hg19::chr19:18529581..18529594,+p@chr19:18529581..18529594
+
Hg19::chr19:18529684..18529699,+p6@SSBP4
Hg19::chr19:36398384..36398407,+p@chr19:36398384..36398407
+
Hg19::chr19:47614483..47614496,-p@chr19:47614483..47614496
-
Hg19::chr19:47834063..47834081,+p@chr19:47834063..47834081
+
Hg19::chr19:50283657..50283673,+p@chr19:50283657..50283673
+
Hg19::chr19:50283684..50283702,+p@chr19:50283684..50283702
+
Hg19::chr19:50284801..50284815,+p@chr19:50284801..50284815
+
Hg19::chr19:50284821..50284856,+p@chr19:50284821..50284856
+
Hg19::chr19:50285177..50285181,+p@chr19:50285177..50285181
+
Hg19::chr19:54710115..54710150,+p@chr19:54710115..54710150
+
Hg19::chr19:55105085..55105136,+p1@LILRA1
Hg19::chr19:55128414..55128437,+p4@LILRB1
Hg19::chr19:55207635..55207643,+p@chr19:55207635..55207643
+
Hg19::chr1:112016594..112016617,+p1@C1orf162
Hg19::chr1:12185656..12185684,+p10@TNFRSF8
Hg19::chr1:12185997..12186018,+p5@TNFRSF8
Hg19::chr1:161519583..161519620,-p1@FCGR3A
Hg19::chr1:161519682..161519691,-p7@FCGR3A
Hg19::chr1:161600900..161600923,-p3@FCGR3B
p4@FCGR3A
Hg19::chr1:181104200..181104242,+p@chr1:181104200..181104242
+
Hg19::chr1:192128293..192128310,+p@chr1:192128293..192128310
+
Hg19::chr1:192128363..192128374,+p@chr1:192128363..192128374
+
Hg19::chr1:26186028..26186052,+p1@ENST00000455431
Hg19::chr1:26186058..26186081,+p2@ENST00000455431
Hg19::chr1:26634917..26634921,+p@chr1:26634917..26634921
+
Hg19::chr20:30793004..30793008,-p@chr20:30793004..30793008
-
Hg19::chr20:62708461..62708503,-p7@RGS19
Hg19::chr20:62711482..62711505,+p4@OPRL1
Hg19::chr20:825275..825293,+p3@FAM110A
Hg19::chr20:825297..825306,+p7@FAM110A
Hg19::chr20:825327..825342,+p4@FAM110A
Hg19::chr20:827656..827661,-p@chr20:827656..827661
-
Hg19::chr21:44765881..44765892,-p@chr21:44765881..44765892
-
Hg19::chr21:45232138..45232176,-p1@LOC284837
Hg19::chr21:45232423..45232443,-p2@LOC284837
Hg19::chr22:30714833..30714846,-p4@TBC1D10A
Hg19::chr2:219125714..219125758,+p1@GPBAR1
Hg19::chr2:219125814..219125822,+p3@GPBAR1
Hg19::chr2:219125838..219125849,+p2@GPBAR1
Hg19::chr2:238600416..238600432,-p@chr2:238600416..238600432
-
Hg19::chr2:241906812..241906837,-p2@LOC200772
Hg19::chr2:241906841..241906868,-p1@LOC200772
Hg19::chr2:241906877..241906887,-p3@LOC200772
Hg19::chr2:29337060..29337092,+p3@CLIP4
Hg19::chr2:29337097..29337111,+p10@CLIP4
Hg19::chr2:29337114..29337117,+p21@CLIP4
Hg19::chr2:71047727..71047733,-p1@CLEC4F
Hg19::chr3:101597149..101597179,+p@chr3:101597149..101597179
+
Hg19::chr3:132036352..132036365,+p6@ACPP
Hg19::chr3:132036369..132036382,+p5@ACPP
Hg19::chr3:196417056..196417097,+p@chr3:196417056..196417097
+
Hg19::chr3:39321512..39321533,-p1@CX3CR1
Hg19::chr3:46968769..46968781,-p@chr3:46968769..46968781
-
Hg19::chr3:50658125..50658131,+p@chr3:50658125..50658131
+
Hg19::chr3:50658577..50658589,+p@chr3:50658577..50658589
+
Hg19::chr4:1582183..1582209,-p1@ENST00000466692
Hg19::chr4:2787568..2787572,+p@chr4:2787568..2787572
+
Hg19::chr4:2794535..2794549,-p@chr4:2794535..2794549
-
Hg19::chr4:3374958..3374970,+p@chr4:3374958..3374970
+
Hg19::chr4:76861392..76861418,-p3@NAAA
Hg19::chr4:76862117..76862186,-p1@NAAA
Hg19::chr5:114887365..114887382,+p@chr5:114887365..114887382
+
Hg19::chr5:14331744..14331753,+p@chr5:14331744..14331753
+
Hg19::chr5:14331797..14331811,+p@chr5:14331797..14331811
+
Hg19::chr5:169064317..169064332,+p2@DOCK2
Hg19::chr5:171601123..171601129,+p@chr5:171601123..171601129
+
Hg19::chr5:172232848..172232850,-p@chr5:172232848..172232850
-
Hg19::chr5:180237681..180237700,+p2@BC017750
Hg19::chr5:56112783..56112806,+p@chr5:56112783..56112806
+
Hg19::chr5:76145904..76145918,+p3@S100Z
Hg19::chr5:76145920..76145948,+p2@S100Z
Hg19::chr6:116782527..116782550,+p4@FAM26F
Hg19::chr6:144952186..144952227,+p@chr6:144952186..144952227
+
Hg19::chr6:144980477..144980514,+p4@UTRN
Hg19::chr6:144980558..144980569,+p30@UTRN
Hg19::chr6:144980756..144980774,+p22@UTRN
Hg19::chr6:144980777..144980799,+p13@UTRN
Hg19::chr6:144980861..144980870,+p38@UTRN
Hg19::chr6:144980916..144980928,+p23@UTRN
Hg19::chr6:144980954..144980988,+p11@UTRN
Hg19::chr6:144981000..144981016,+p14@UTRN
Hg19::chr6:31553978..31554060,+p1@LST1
Hg19::chr6:31554755..31554764,+p11@LST1
Hg19::chr6:31554766..31554777,+p8@LST1
Hg19::chr6:31554826..31554845,+p4@LST1
Hg19::chr6:31554962..31554987,+p5@LST1
Hg19::chr6:31554992..31555041,+p2@LST1
Hg19::chr6:31555045..31555057,+p9@LST1
Hg19::chr6:31582990..31583096,+p1@AIF1
Hg19::chr6:31584663..31584673,-p@chr6:31584663..31584673
-
Hg19::chr7:101923300..101923343,+p@chr7:101923300..101923343
+
Hg19::chr7:155055063..155055078,+p@chr7:155055063..155055078
+
Hg19::chr7:20581331..20581339,-p@chr7:20581331..20581339
-
Hg19::chr7:20581377..20581387,-p@chr7:20581377..20581387
-
Hg19::chr7:2673037..2673047,-p@chr7:2673037..2673047
-
Hg19::chr7:2673206..2673216,+p@chr7:2673206..2673216
+
Hg19::chr7:2673688..2673709,-p@chr7:2673688..2673709
-
Hg19::chr7:5596053..5596074,-p@chr7:5596053..5596074
-
Hg19::chr7:77429034..77429040,-p@chr7:77429034..77429040
-
Hg19::chr8:142384243..142384251,+p@chr8:142384243..142384251
+
Hg19::chr8:142384271..142384329,+p@chr8:142384271..142384329
+
Hg19::chr8:143833918..143833960,-p1@LYPD2
Hg19::chr8:143833961..143833974,-p2@LYPD2
Hg19::chr8:144480343..144480350,-p@chr8:144480343..144480350
-
Hg19::chr8:37439077..37439090,+p@chr8:37439077..37439090
+
Hg19::chr8:38758006..38758019,+p@chr8:38758006..38758019
+
Hg19::chr8:52811117..52811133,+p@chr8:52811117..52811133
+
Hg19::chr9:130540914..130540932,-p5@SH2D3C
Hg19::chr9:136709727..136709738,+p@chr9:136709727..136709738
+
Hg19::chr9:137267629..137267639,-p@chr9:137267629..137267639
-
Hg19::chr9:137267647..137267658,-p@chr9:137267647..137267658
-
Hg19::chr9:138967894..138967906,-p@chr9:138967894..138967906
-
Hg19::chr9:140348244..140348308,-p@chr9:140348244..140348308
-
Hg19::chrX:70712265..70712303,+p4@TAF1
Hg19::chrY:2870975..2870988,+p1@LINC00278


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0016020membrane9.32023741352661e-06
GO:0004871signal transducer activity4.97454272835934e-05
GO:0060089molecular transducer activity4.97454272835934e-05
GO:0044425membrane part0.000885377741452317
GO:0008285negative regulation of cell proliferation0.0010982489843916
GO:0019864IgG binding0.00389780543213328
GO:0050672negative regulation of lymphocyte proliferation0.00492500838025483
GO:0032945negative regulation of mononuclear cell proliferation0.00492500838025483
GO:0048523negative regulation of cellular process0.00492500838025483
GO:0004872receptor activity0.00492500838025483
GO:0044464cell part0.00492500838025483
GO:0048519negative regulation of biological process0.00520183320258003
GO:0019865immunoglobulin binding0.00688185411257371
GO:0016021integral to membrane0.00688185411257371
GO:0031224intrinsic to membrane0.00688185411257371
GO:0005886plasma membrane0.00688185411257371
GO:0051250negative regulation of lymphocyte activation0.00832577728169739
GO:0032403protein complex binding0.00879372966006079
GO:0042127regulation of cell proliferation0.00921920829385283
GO:0008283cell proliferation0.00968728738051494
GO:0030595leukocyte chemotaxis0.00993913319223597
GO:0050900leukocyte migration0.0173228094301686
GO:0042330taxis0.0181469423724365
GO:0006935chemotaxis0.0181469423724365
GO:0007166cell surface receptor linked signal transduction0.0181469423724365
GO:0006952defense response0.0181469423724365
GO:0007165signal transduction0.018334818823925
GO:0045554regulation of TRAIL biosynthetic process0.0188999696750325
GO:0043129surfactant homeostasis0.0188999696750325
GO:0045553TRAIL biosynthetic process0.0188999696750325
GO:0048875chemical homeostasis within a tissue0.0188999696750325
GO:0032639TRAIL production0.0188999696750325
GO:0045556positive regulation of TRAIL biosynthetic process0.0188999696750325
GO:0009605response to external stimulus0.0188999696750325
GO:0005737cytoplasm0.0188999696750325
GO:0032944regulation of mononuclear cell proliferation0.0188999696750325
GO:0050670regulation of lymphocyte proliferation0.0188999696750325
GO:0006928cell motility0.0198542754536055
GO:0051674localization of cell0.0198542754536055
GO:0007626locomotory behavior0.0214749844586034
GO:0002376immune system process0.0236206013010033
GO:0030695GTPase regulator activity0.0249523236786799
GO:0032943mononuclear cell proliferation0.0252075945113539
GO:0046651lymphocyte proliferation0.0252075945113539
GO:0044459plasma membrane part0.0260685840256939
GO:0005515protein binding0.0276131105418551
GO:0019807aspartoacylase activity0.0276131105418551
GO:0047696beta-adrenergic receptor kinase activity0.0276131105418551
GO:0042035regulation of cytokine biosynthetic process0.0289078836085141
GO:0007154cell communication0.0299010405478368
GO:0016477cell migration0.0331147653005901
GO:0042089cytokine biosynthetic process0.0331147653005901
GO:0042107cytokine metabolic process0.0331147653005901
GO:0033209tumor necrosis factor-mediated signaling pathway0.0331147653005901
GO:0048286alveolus development0.0331147653005901
GO:0022401adaptation of signaling pathway0.0331147653005901
GO:0008157protein phosphatase 1 binding0.0331147653005901
GO:0002029desensitization of G-protein coupled receptor protein signaling pathway0.0331147653005901
GO:0045085negative regulation of interleukin-2 biosynthetic process0.0331147653005901
GO:0042608T cell receptor binding0.0331147653005901
GO:0006955immune response0.0344981384493859
GO:0051249regulation of lymphocyte activation0.0363072331852681
GO:0050865regulation of cell activation0.0389339002729788
GO:0045744negative regulation of G-protein coupled receptor protein signaling pathway0.0389339002729788
GO:0048246macrophage chemotaxis0.0389339002729788
GO:0048247lymphocyte chemotaxis0.0389339002729788
GO:0015051X-opioid receptor activity0.0389339002729788
GO:0004046aminoacylase activity0.0389339002729788
GO:0007186G-protein coupled receptor protein signaling pathway0.039985979963799
GO:0051329interphase of mitotic cell cycle0.039985979963799
GO:0051239regulation of multicellular organismal process0.0400152244196185
GO:0000267cell fraction0.0427906431484107
GO:0051325interphase0.0428389829493994
GO:0050828regulation of liquid surface tension0.0440488207431105
GO:0042535positive regulation of tumor necrosis factor biosynthetic process0.0440488207431105
GO:0007610behavior0.0440488207431105
GO:0005085guanyl-nucleotide exchange factor activity0.0498283844727028



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
classical monocyte2.57e-12442
CD14-positive, CD16-negative classical monocyte2.57e-12442
defensive cell2.21e-10748
phagocyte2.21e-10748
monopoietic cell1.08e-8759
monocyte1.08e-8759
monoblast1.08e-8759
promonocyte1.08e-8759
macrophage dendritic cell progenitor1.70e-8461
myeloid leukocyte1.16e-8172
myeloid lineage restricted progenitor cell2.40e-7766
granulocyte monocyte progenitor cell4.84e-7667
stuff accumulating cell3.03e-5487
nongranular leukocyte1.49e-53115
myeloid cell8.80e-51108
common myeloid progenitor8.80e-51108
leukocyte2.32e-50136
hematopoietic lineage restricted progenitor cell7.30e-44120
hematopoietic stem cell1.99e-38168
angioblastic mesenchymal cell1.99e-38168
hematopoietic cell7.61e-36177
hematopoietic oligopotent progenitor cell4.03e-35161
hematopoietic multipotent progenitor cell4.03e-35161
intermediate monocyte1.09e-289
CD14-positive, CD16-positive monocyte1.09e-289
mesenchymal cell9.60e-12354
connective tissue cell2.79e-11361
non-classical monocyte3.13e-113
CD14-low, CD16-positive monocyte3.13e-113
basophil9.76e-113
single nucleate cell6.60e-103
mononuclear cell6.60e-103
motile cell1.18e-09386
multi fate stem cell1.10e-07427
somatic stem cell2.04e-07433
stem cell4.53e-07441
Uber Anatomy
Ontology termp-valuen
hematopoietic system7.66e-8798
blood island7.66e-8798
hemolymphoid system1.20e-80108
bone marrow7.87e-6676
immune system1.27e-6293
bone element2.97e-6082
skeletal element5.79e-5490
skeletal system1.67e-47100
lateral plate mesoderm2.05e-35203
musculoskeletal system4.11e-24167
mesoderm3.63e-19315
mesoderm-derived structure3.63e-19315
presumptive mesoderm3.63e-19315
blood5.57e-1815
haemolymphatic fluid5.57e-1815
organism substance5.57e-1815
connective tissue1.19e-10371


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs



JASPAR motifs

Motifs-log10(p-value)
MA0003.10.107657
MA0004.10.524825
MA0006.10.0792944
MA0007.10.2248
MA0009.10.0785646
MA0014.10.00604283
MA0017.10.527005
MA0019.10.136127
MA0024.10.0349195
MA0025.10.0438943
MA0027.11.14523
MA0028.10.0714498
MA0029.10.244941
MA0030.10.228152
MA0031.10.444217
MA0038.10.512162
MA0040.10.253759
MA0041.10.024857
MA0042.10.100111
MA0043.10.0173155
MA0046.10.0729545
MA0048.10.236793
MA0050.10.101387
MA0051.10.231902
MA0052.10.12533
MA0055.11.18739
MA0056.10
MA0057.10.540272
MA0058.11.03121
MA0059.10.844689
MA0060.10.00153203
MA0061.10.0515203
MA0063.10
MA0066.13.07373
MA0067.10.352304
MA0068.10.303382
MA0069.10.362561
MA0070.10.0656211
MA0071.11.34689
MA0072.11.18607
MA0073.10.236739
MA0074.10.141301
MA0076.10.0321883
MA0077.10.0600262
MA0078.10.512474
MA0081.12.41667
MA0083.10.0183531
MA0084.10.207585
MA0087.10.0624003
MA0088.12.08506
MA0089.10
MA0090.10.258322
MA0091.10.697148
MA0092.10.368299
MA0093.10.653873
MA0095.10
MA0098.10
MA0100.10.0486853
MA0101.10.0580521
MA0103.10.268655
MA0105.10.428085
MA0106.10.907238
MA0107.10.0220736
MA0108.20.00325094
MA0109.10
MA0111.10.690246
MA0113.10.0815544
MA0114.11.00911
MA0115.10.268062
MA0116.14.1658
MA0117.10.0999228
MA0119.11.66474
MA0122.10.116434
MA0124.10.0633695
MA0125.10.154028
MA0130.10
MA0131.10.247819
MA0132.10
MA0133.10
MA0135.10.44952
MA0136.12.0668
MA0139.10.0322007
MA0140.10.36119
MA0141.10.53782
MA0142.10.555126
MA0143.10.15405
MA0144.10.0113096
MA0145.10.501795
MA0146.11.68845
MA0147.10.138517
MA0148.10.65268
MA0149.14.3059
MA0062.20.0423768
MA0035.20.0915031
MA0039.22.4389
MA0138.20.72117
MA0002.20.324963
MA0137.20.00795194
MA0104.20.0600514
MA0047.20.313123
MA0112.22.97413
MA0065.22.76392
MA0150.10.108782
MA0151.10
MA0152.10.00269712
MA0153.10.0353782
MA0154.14.1115
MA0155.12.98798
MA0156.10.837693
MA0157.10.0885999
MA0158.10
MA0159.11.02096
MA0160.10.294889
MA0161.10
MA0162.14.81311e-06
MA0163.11.1909
MA0164.10.431322
MA0080.27.20307
MA0018.20.132752
MA0099.20.00932172
MA0079.20.00271096
MA0102.20.230633
MA0258.11.63488
MA0259.10.165675
MA0442.10



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
SPI1#6688592.396312311895258.62809779252941e-119.43570581522491e-09



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=Coexpression_cluster:C92&oldid=3067210"